Rapamycin modulates the maturation of rat bone marrow-derived dendritic cells

Abstract

The purpose of the study was to observe the effect of rapamycin (RAPA) on the differentiation and maturation of rat bone marrow-derived dendritic cells (BMDCs) in vitro. BMDCs from Wistar rats were cultured with granulocyte-macrophage colony-stimulating factor plus interleukin-4 in the presence or absence of RAPA (20 ng/mL), and stimulated with lipopolysaccharide (LPS) for 24 h before cells and supernatants were collected. Surface phenotype of BMDCs was flow-cytometrically detected to determine the expression of maturation markers, MHC class II and CD86. Supernatants were analyzed for the production of IL-12 and IFN-γ cytokines by using ELISA. BMDCs were co-cultured with T cells from Lewis rats and mixed lymphocyte reaction was assessed by MTT method. The morphology of BMDCs stimulated with LPS remained immature after RAPA pretreatment. RAPA significantly decreased the CD86 expression, impaired the IL-12 and IFN-γ production of BMDCs stimulated with LPS, and inhibited the proliferation of allogeneic T cells. In conclusion, RAPA can inhibit the maturation of BMDCs stimulated with LPS in terms of the morphology, surface phenotype, cytokine production, and ability of BMDCs to stimulate the proliferation of allogeneic T cells in vitro.

Keywords

rat / dendritic cells / rapamycin

References

[1] BanchereauJ., BriereF., CauxC., et al.. Immunobiology of dendritic cells. Annu Rev Immunol, 2000, 18: 767-811

[2] BanchereauJ., SteinmanR. M.. Dendritic cells and the control of immunity. Nature, 1998, 392: 245-252

[3] Reis e SousaC.. Dendritic cells in a mature age. Nat Rev Immunol, 2006, 6(6): 476-483

[4] SteinmanR. M., HawigerD., NussenzweigM. C.. Tolerogenic dendritic cells. Annu Rev Immunol, 2003, 21: 685-711

[5] JonuleitH., SchmittE., SchulerG., et al.. Induction of interleukin 10-producing, non-proliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med, 2000, 192: 1213-1222

[6] FuF., LiY., QianS., et al.. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II⁺, CD80^dim, CD86⁻) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation, 1996, 62: 659-665

[7] DhodapkarM. V., SteinmanR. M., KrasovskyJ., et al.. Antigen-specific inhibition of effector T cell in humans after injection of immature dendritic cells. J Exp Med, 2001, 193: 233-238

[8] SaundersR. N., MetcalfeM. S., NicholsonM. L., et al.. Rapamycin in transplantation: a review of the evidence. Kidney Int, 2001, 59: 3-16

[9] ChanM., PearsonG. J.. New advances in antirejection therapy. Curr Opin Cardiol, 2007, 22(2): 117-122

[10] SigalN. H., DumontF. J., CyclosporinA.. FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol, 1992, 10: 519-560

[11] MariottiJ., FoleyJ., JungU., et al.. Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection. J Immunol, 2008, 180(1): 89-105

[12] HoribeE. K., SacksJ., UnadkatJ., et al.. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl Immunol, 2008, 18(4): 307-318

[13] BertagnolliM. M., YangL., HerrmannS. H., et al.. Evidence that rapamycin inhibits interlerukin-12-induced proliferation of activated T lymphocytes. Transplantation, 1994, 58: 1091-1096

[14] Aaguaard-TilleryK. M., JelinekD. F.. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol, 1994, 156: 493-507

[15] MatsueH., YangC., MatsueK., et al.. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol, 2002, 169: 3555-3564

[16] ChiangP. H., WangL., BonhamC. A., et al.. Mechanistic insights into impaired dendritic cell function by rapamycin: Inhibition of Jak2/Stat4 signaling pathway. J Immunol, 2004, 172: 1355-1363

[17] HacksteinH., TanerT., ZahorchakA. F., et al.. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood, 2003, 101: 4457-4463

[18] WoltmanA. M., de FijterJ. W., KamerlingS. W., et al.. Rapamycin induces apoptosis in monocyte-and CD34-derived dendritic cells but not in monocytes and macrophages. Blood, 2001, 98: 174-180

[19] MontiP., MercalliA., LeoneB. E., et al.. Rapamycin impairs antigen uptake of human dendritic cells. Transplantation, 2003, 75: 137-145

[20] TanerT., HacksteinH., WangZ., et al.. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant, 2005, 5: 228-236

[21] MurphyK. M., OuyangW., FarrarJ. D., et al.. Signaling and transcription in T helper development. Annu Rev Immunol, 2000, 18: 451-494

[22] KishimotoK., DongV. M., SayeghM. H.. The role of costimulatory molecules as targets for new immunosuppressive in transplantation. Curr Opini Urol, 2000, 10(2): 57-62

[23] MacatoniaS., HoskenN., LittonM., et al.. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol, 1995, 154: 5071-5079

[24] TrinchieriG.. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 2003, 3(2): 133-146

[25] BianchiR., GrohmannU., VaccaC., et al.. Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation. J Immunol, 1999, 63: 2517-2521

[26] BoehmU., KlampT., GrootM., et al.. Cellular responses to interferon-gamma. Annu Rev Immunol, 1997, 15: 749-795

[27] WatanabeH., UngerM., TuvelB., et al.. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res, 2002, 22(4): 407-412

[28] OhtekiT., FukaoT., SuzueK., et al.. Interleukin 12-dependent interferon-γ production by CD8alpha+ lymphoid dendritic cells. J Exp Med, 1999, 189: 1981-1986

[29] WalzerT., DalodM., VivierE., et al.. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther, 2005, 5(Suppl1): S49-S59

[30] StoberD., SchirmbeckR., ReimannJ.. IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J Immunol, 2001, 167: 957-965